{
  "protocolSection": {
    "identificationModule": null,
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "patientRegistry": false,
      "targetDuration": null,
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "RANDOMIZED",
        "interventionModel": "PARALLEL",
        "interventionModelDescription": "Participants were randomized 3:2 to treatment with either exenatide (n=127) titrated to maximum dosing of 10mcg daily or hypocaloric diet with placebo injections (n=55). There was no run-in period.",
        "primaryPurpose": "TREATMENT",
        "observationalModel": null,
        "timePerspective": null,
        "maskingInfo": {
          "masking": "SINGLE",
          "maskingDescription": "All subjects were blinded to study treatment. This was a single-blind interventional trial where participants did not know whether they received exenatide or placebo injections. Study staff who measured body weight, waist circumference, vital signs and body composition were also blinded to study treatment.",
          "whoMasked": [
            "PARTICIPANT",
            "OUTCOMES_ASSESSOR"
          ]
        }
      },
      "enrollmentInfo": {
        "count": 182,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": null,
    "outcomesModule": null,
    "eligibilityModule": null
  }
}